BOSTON ( TheStreet) -- The People's Republic of China, despite talk of a bubble, still offers investment opportunities superior to those in many developed nations, including the U.S. Here are five U.S.-listed China small-caps with outstanding prospects and "buy" ratings.

5. China Automotive Systems ( CAAS) makes power-steering systems and car components.

Numbers: Third-quarter profit more than tripled to $8.6 million, or 28 cents a share, as revenue increased 75% to $65 million. The operating margin expanded from 9.1% to 14%. The company holds $55 million of cash and $60 million of debt.

Stock: China Automotive Systems has advanced 669% in the past year, trouncing U.S. benchmarks. The stock trades at a price-to-projected-earnings ratio of 27, a 31% discount to the industry average. Its PEG ratio, a measure of value relative to growth, is low at 0.6. A PEG ratio below 1 implies cheap shares.

Catalyst: China overtook the U.S. in 2009 to become the world's largest car market. Last year, its domestic industry grew by an estimated 50%. China is spurring growth by offering consumer incentives. Domestic players enjoy preferential treatment.

Consensus: Of five analysts surveyed by Bloomberg, two recommend buying the shares and the remainder advise holding. During the past three years, the stock has gained 37% annually, on average. It ranks in the top 8% of TheStreet's coverage universe.

4. Shanda Interactive ( SNDA) operates online games.

Numbers: Fourth-quarter profit increased 8% to $54 million, or 78 cents a share, as revenue soared 49% to $222 million. Shanda's operating margin contracted from 44% to 37%. Its balance sheet contains $1.9 billion of cash and $153 million of debt.

Stock: Shanda Interactive increased 22% over the past 12 months, less than U.S. indices. The stock sells for a price-to-projected-earnings ratio of 11, a 50% discount to the industry average. The shares are also cheap based on book value and sales.

Catalyst: Internet penetration is rising in China as it tapers in the U.S. Online gaming is a national phenomenon, with roughly 70 million participating. The industry is expected to double in the next few years. Shanda holds a top-three market share.

Consensus: Of 21 analysts covering Shanda, 10 recommend purchasing the shares, nine suggest holding and two advise selling. The stock has returned 19%, annually, over the past three years. It ranks in the top 6% of our coverage universe.

3. China Sky One Medical ( CSKI) sells supplements and over-the-counter drugs.

Numbers: Third-quarter profit grew 25% to $12 million, or 74 cents a share, as revenue climbed 46% to $43 million. China Sky One's operating margin narrowed from 42% to 37%. Its balance sheet stores $56 million of cash and no debt.

Stock: China Sky One Medical appreciated 52% in the past year, trailing U.S. benchmarks. The stock trades at a price-to-projected-earnings ratio of 5.9, a 64% discount to the peer group average. Its PEG ratio of 0.3 indicates a bargain based on expected growth.

Catalyst: Concerns about competition and product quality have dogged this stock in recent months, but its diversification into medical-testing kits and bio-engineering products is likely to bolster growth. Its net cash position should reduce trepidation.

Consensus: Just three analysts follow China Sky One, and they all advocate purchasing the shares. The most bullish price target comes from Singular Research, which expects the stock to rise 77% to $28.50. It places in the top 6% of our coverage universe.

2. Jinpan International ( JST) makes transformers for infrastructure development.

Numbers: Third-quarter profit soared 82% to $9.4 million, or 58 cents a share, as revenue declined 1.9% to $44 million. Jinpan's operating margin extended from 16% to 22%. Its balance sheet houses $38 million of cash and $26 million of debt.

Stock: Jinpan has quadrupled in the past 12 months, outperforming major indices. The stock sells for a price-to-projected-earnings ratio of 14, a 27% discount to the peer-group average. The shares are also cheap based on book value and cash flow.

Catalyst: China's $586 billion stimulus has another year of payouts and about 38% is allocated to infrastructure development. Jinpan received an Underwriters Laboratories, or UL, certification in 2009 and is now exporting to developed economies.

Consensus: Only two analysts cover Jinpan, but both advocate buying the shares. Roth Capital expects the stock to appreciate 20% to $29. It has gained 39%, on average, during the past three years, landing in the top 4% of stocks we cover.

1. AsiaInfo ( ASIA) sells telecommunications software and IT-security products.

Numbers: Fourth-quarter profit multiplied sixfold to $14 million, or 29 cents a share, as revenue climbed 42% to $76 million. The operating margin widened from 15% to 19%. AsiaInfo holds $285 million of cash, equating to a quick ratio of 2.1, and no debt.

Stock: AsiaInfo has soared 143% over the past year, beating major benchmarks. The stock trades at a price-to-projected-earnings ratio of 18, a 14% discount to the industry average. Its PEG ratio of 0.6 reflects a bargain relative to expected growth.

Catalyst: China's telecom-software spending is expected to grow 15% a year through 2012. One of two telecom users is served by AsiaInfo's systems. Expansion into the IT-security market is a safe diversification as government agencies drive growth.

Consensus: Seven of eight analysts that follow AsiaInfo advocate purchasing shares. The stock gained 61%, on average, during the past three years. Pacific Crest Securities projects it will climb 43% to $40. It ranks in the top 3% of our coverage universe.

-- Reported by Jake Lynch in Boston.

If you liked this article you might like

China Sky One Medical Inc. Stock Downgraded (CSKI)

China Sky One Medical Inc. Stock Downgraded (CSKI)

China Sky One Medical Stock Soars (CSKI)

China Sky One Medical Stock Soars (CSKI)

China Sky One Medical Stock Soars (CSKI)

China Sky One Medical Stock Soars (CSKI)

China Reverse Mergers Continue Wild Ride

China Reverse Mergers Continue Wild Ride

SEC Could Use 'Naked-Shorting,' Apple Alerts

SEC Could Use 'Naked-Shorting,' Apple Alerts